tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Humacyte announces results in high-risk dialysis from V007 Pivotal Phase 3
PremiumThe FlyHumacyte announces results in high-risk dialysis from V007 Pivotal Phase 3
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
Merck, Regeneron, Cellectar, Humacyte, Foot Locker: Trending by Analysts
Premium
Weekend Updates
Merck, Regeneron, Cellectar, Humacyte, Foot Locker: Trending by Analysts
2M ago
Humacyte assumed with a Buy at H.C. Wainwright
PremiumThe FlyHumacyte assumed with a Buy at H.C. Wainwright
2M ago
Humacyte price target lowered to $14 from $17 at Benchmark
Premium
The Fly
Humacyte price target lowered to $14 from $17 at Benchmark
2M ago
Humacyte’s Promising Growth: Strong Financials and Successful Symvess Launch Drive Buy Rating
Premium
Ratings
Humacyte’s Promising Growth: Strong Financials and Successful Symvess Launch Drive Buy Rating
2M ago
Insider Moves: Humacyte, Aeva, Copart, Transdigm, Rockwell
PremiumWeekend UpdatesInsider Moves: Humacyte, Aeva, Copart, Transdigm, Rockwell
3M ago
Humacyte Challenges FDA Petition Amidst Controversy
Premium
Company Announcements
Humacyte Challenges FDA Petition Amidst Controversy
3M ago
Humacyte’s Promising Market Penetration and Revenue Projections Justify Buy Rating
Premium
Ratings
Humacyte’s Promising Market Penetration and Revenue Projections Justify Buy Rating
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100